Healthcare Economics & Policy

Once a child’s broken arm is on the mend, little to nothing is gained by having follow-up x-rays read by both radiologists and orthopedic surgeons, according to a study conducted at Case Western Reserve University and published online March 6 in the Journal of Pediatric Orthopaedics.

U.S. Senators Pat Toomey, R-Pennsylvania and Amy Klobuchar D-Minnesota introduced bipartisan legislation, Thursday, March 7, to permanently repeal the 2.3 percent medical device tax.

Carestream Health has signed an agreement to sell its healthcare information systems (HCIS) business to Royal Philips, the company announced Thursday, March 7. The deal is expected to close in the second half of this year.

The upcoming vote on whether the U.K. will leave the European Union has prompted the Royal College of Radiologists (RCR) to warn doctors of a potential delay in receiving drugs used to detect and treat cancer, the BBC reported.

The International Contrast Ultrasound Society (ICUS) is again urging the FDA to remove the “black box” warning from ultrasound contrast agent (UCA) labels, following its filing of a September 2018 citizen petition with the federal agency.

The American College of Radiology (ACR) and American Association of Physicists in Medicine (AAPM) released a joint statement Monday, March 5, to quell potential fears sparked by a recent research letter investigating the presence of radioactive materials in cremated bodies.

The American College of Radiology (ACR) is asking for comments to be submitted by April 15.

A radiologist in Tennessee has filed a federal class action lawsuit against the American Board of Radiology (ABR) that alleges the ABR is in violation of antitrust laws.

"The takeaway here is that screening does matter, and the expansion of Medicaid has increased usage of colon cancer screening for many Kentuckians who otherwise wouldn't have had access," wrote authors of a Feb. 22 study published in the Journal of the American College of Surgeons.

“This legislation is an important step in ensuring patients are appropriately notified about their risk of breast cancer so they can make informed decisions about their care,” Dennis Durmis, chair of MITA’s Board of Directors, said in a prepared statement. 

General Electric (GE) may be halting its plan for an initial public offering (IPO) of its healthcare sector in 2019, GE Chairman and CEO Larry Culp told CNBC on Feb. 25. The announcement came after the company made a deal to sell its biopharma business to Danaher for $21.4 billion.

“There is no valid scientific data to show that thermographic devices, when used on their own or with another diagnostic test, are an effective screening tool for any medical condition, including the early detection of breast cancer or other diseases and conditions,” the FDA wrote. “The agency stresses that mammography is the only screening method proven to reduce deaths from breast cancer through early detection.”